200 related articles for article (PubMed ID: 35764091)
1. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
Zhou J; Simon JM; Liao C; Zhang C; Hu L; Zurlo G; Liu X; Fan C; Hepperla A; Jia L; Tcheuyap VT; Zhong H; Elias R; Ye J; Henne WM; Kapur P; Nijhawan D; Brugarolas J; Zhang Q
Mol Cell; 2022 Aug; 82(16):3030-3044.e8. PubMed ID: 35764091
[TBL] [Abstract][Full Text] [Related]
2. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
Mitra R; Le TT; Gorjala P; Goodman OB
BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685
[TBL] [Abstract][Full Text] [Related]
3. Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
Zhang C; Lu X; Huang J; He H; Chen L; Liu Y; Wang H; Xu Y; Xing S; Ruan X; Yang X; Chen L; Xu D
Clin Transl Med; 2021 Feb; 11(2):e328. PubMed ID: 33634984
[TBL] [Abstract][Full Text] [Related]
4. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.
Wang K; Yang C; Li H; Liu X; Zheng M; Xuan Z; Mei Z; Wang H
Front Immunol; 2022; 13():859893. PubMed ID: 35359945
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma.
Zhang W; Liu R; Zhang L; Wang C; Dong Z; Feng J; Luo M; Zhang Y; Xu Z; Lv S; Wei Q
Cancer Gene Ther; 2022 May; 29(5):573-584. PubMed ID: 33888871
[TBL] [Abstract][Full Text] [Related]
8. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
9. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
10. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells.
Shen C; Quan Q; Yang C; Wen Y; Li H
Stem Cell Res Ther; 2018 Aug; 9(1):212. PubMed ID: 30092848
[TBL] [Abstract][Full Text] [Related]
12. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells.
Sung PS; Murayama A; Kang W; Kim MS; Yoon SK; Fukasawa M; Kondoh M; Kim JS; Kim H; Kato T; Shin EC
J Virol; 2014 Aug; 88(16):9233-44. PubMed ID: 24899196
[TBL] [Abstract][Full Text] [Related]
14. Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells.
Morales A; Greenberg M; Nardi F; Gil V; Hayward SW; Crawford SE; Franco OE
Lab Invest; 2021 Jul; 101(7):921-934. PubMed ID: 33824421
[TBL] [Abstract][Full Text] [Related]
15. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
16. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
18. Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis.
Jin Y; McFie PJ; Banman SL; Brandt C; Stone SJ
J Biol Chem; 2014 Oct; 289(41):28237-48. PubMed ID: 25164810
[TBL] [Abstract][Full Text] [Related]
19. Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia.
Alahari S; Post M; Rolfo A; Weksberg R; Caniggia I
J Clin Endocrinol Metab; 2018 Apr; 103(4):1545-1557. PubMed ID: 29373688
[TBL] [Abstract][Full Text] [Related]
20. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
